Suppr超能文献

通过药物递送凝胶对人体阴道涂层进行光学成像与分析。

Optical imaging and analysis of human vaginal coating by drug delivery gels.

作者信息

Henderson Marcus H, Couchman Grace M, Walmer David K, Peters Jennifer J, Owen Derek H, Brown Matthew A, Lavine Michael L, Katz David F

机构信息

Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.

出版信息

Contraception. 2007 Feb;75(2):142-51. doi: 10.1016/j.contraception.2006.08.014. Epub 2006 Oct 31.

Abstract

OBJECTIVE

We used a new optical imaging technique to compare human intravaginal coating distributions of Conceptrol (Advanced Care Products, Brunswick, NJ) and Advantage (Columbia Laboratories, Aventuna, FL). These gels are surrogates for future microbicidal gels, differing in molecular structures and biophysical properties.

METHODS

For each protocol, a 3-mL gel bolus was inserted to the posterior fornix while the woman was in the supine position. She then either (1) remained supine (10 min); or (2) sat up (1 min), stood up (1 min), sat down (1 min) and returned to supine for a net elapsed time of 10 min. The imaging device is sized/shaped like a phallus, and measurements while the device was inserted provide data that simulate peri-intromission coating.

RESULTS

Coating by Advantage was more extensive and uniform than coating by Conceptrol, with smaller bare spots of uncoated epithelium. Change in posture tended to increase extent and uniformity of coating, details differing between gels.

CONCLUSIONS

Results are consistent with predictions of mechanistic coating theory, using gel rheological data as inputs.

摘要

目的

我们使用一种新的光学成像技术比较了Conceptrol(高级护理产品公司,新泽西州布伦瑞克)和Advantage(哥伦比亚实验室,佛罗里达州阿文图纳)在人体阴道内的涂层分布情况。这些凝胶是未来杀微生物凝胶的替代品,在分子结构和生物物理特性方面存在差异。

方法

对于每个方案,在女性仰卧位时将3毫升凝胶团块插入后穹窿。然后她要么(1)保持仰卧位(10分钟);要么(2)坐起(1分钟)、站立(1分钟)、坐下(1分钟),然后再回到仰卧位,总耗时10分钟。成像设备的尺寸/形状类似阴茎,在插入设备时进行测量可提供模拟插入时涂层的数据。

结果

Advantage形成的涂层比Conceptrol更广泛、更均匀,未涂层上皮的裸露斑点更小。姿势变化往往会增加涂层的范围和均匀性,不同凝胶的具体情况有所不同。

结论

结果与将凝胶流变学数据作为输入的机械涂层理论预测一致。

相似文献

1
Optical imaging and analysis of human vaginal coating by drug delivery gels.
Contraception. 2007 Feb;75(2):142-51. doi: 10.1016/j.contraception.2006.08.014. Epub 2006 Oct 31.
2
Comparison of the rheological properties of Advantage-S and Replens.
Contraception. 2001 Dec;64(6):393-6. doi: 10.1016/s0010-7824(01)00278-5.
4
Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis.
J Pharm Sci. 2004 Dec;93(12):2941-52. doi: 10.1002/jps.20194.
5
Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
J Biomech Eng. 2006 Aug;128(4):540-53. doi: 10.1115/1.2206198.
7
Rheological properties of contraceptive gels.
Contraception. 2000 Dec;62(6):321-6. doi: 10.1016/s0010-7824(00)00184-0.
8
Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Drug Dev Ind Pharm. 2013 Sep;39(9):1328-37. doi: 10.3109/03639045.2012.707204. Epub 2012 Aug 7.
10
GM-144, a novel lipophilic vaginal contraceptive gel-microemulsion.
AAPS PharmSciTech. 2001 Apr 9;2(2):E5. doi: 10.1208/pt020205.

引用本文的文献

1
Mutual Preservation: A Review of Interactions Between Cervicovaginal Mucus and Microbiota.
Front Cell Infect Microbiol. 2021 Jul 13;11:676114. doi: 10.3389/fcimb.2021.676114. eCollection 2021.
2
Measuring dilution of microbicide gels with optical imaging.
PLoS One. 2013 Dec 10;8(12):e82213. doi: 10.1371/journal.pone.0082213. eCollection 2013.
3
Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.
Am J Obstet Gynecol. 2013 Apr;208(4):282.e1-7. doi: 10.1016/j.ajog.2013.01.025. Epub 2013 Jan 17.
5
Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.
Mucosal Immunol. 2013 Mar;6(2):427-34. doi: 10.1038/mi.2012.87. Epub 2012 Sep 19.
6
Factors Important to the Prioritization and Development of Successful Topical Microbicides for HIV-1.
Mol Biol Int. 2012;2012:781305. doi: 10.1155/2012/781305. Epub 2012 Jul 12.
7
Using modeling to help understand vaginal microbicide functionality and create better products.
Drug Deliv Transl Res. 2011 Jun;1(3):256-76. doi: 10.1007/s13346-011-0029-z. Epub 2011 May 17.
9
Inhibition of the transport of HIV in vitro using a pH-responsive synthetic mucin-like polymer system.
Biomaterials. 2011 Nov;32(33):8343-55. doi: 10.1016/j.biomaterials.2011.05.001. Epub 2011 Aug 27.
10
Clinical evaluation of microbicide formulations.
Antiviral Res. 2010 Dec;88 Suppl 1(Suppl 1):S40-6. doi: 10.1016/j.antiviral.2010.09.008.

本文引用的文献

1
Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.
Biophys J. 2006 Sep 15;91(6):2121-30. doi: 10.1529/biophysj.106.086322. Epub 2006 Jun 30.
2
Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery.
J Biomech Eng. 2006 Aug;128(4):540-53. doi: 10.1115/1.2206198.
3
The optimal analysis of MRI data to quantify the distribution of a microbicide.
Contraception. 2006 Jan;73(1):82-7. doi: 10.1016/j.contraception.2005.07.005. Epub 2005 Sep 19.
5
In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
Contraception. 2004 Dec;70(6):498-505. doi: 10.1016/j.contraception.2004.06.013.
6
Effect of temperature and pH on contraceptive gel viscosity.
Contraception. 2003 Jan;67(1):57-64. doi: 10.1016/s0010-7824(02)00430-4.
8
Comparison of the rheological properties of Advantage-S and Replens.
Contraception. 2001 Dec;64(6):393-6. doi: 10.1016/s0010-7824(01)00278-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验